Borland, Colin, Bryan Mist, Mariella Zammit, and Alain Vuylsteke. Steady-state measurement of NO and CO lung diffusing capacity on moderate exercise in men. J Appl Physiol 90: [538][539][540][541][542][543][544] 2001.-Using a rapidly responding nitric oxide (NO) analyzer, we measured the steady-state NO diffusing capacity (DL NO ) from end-tidal NO. The diffusing capacity of the alveolar capillary membrane and pulmonary capillary blood volume were calculated from the steady-state diffusing capacity for CO (measured simultaneously) and the specific transfer conductance of blood per milliliter for NO and for CO. Nine men were studied bicycling at an average O 2 consumption of 1.3 Ϯ 0.2 l/min (mean Ϯ SD). DL NO was 202.7 Ϯ 71.2 ml⅐min Ϫ1 ⅐Torr Ϫ1 and steady-state diffusing capacity for CO, calculated from end-tidal (assumed alveolar) CO 2 , mixed expired CO 2 , and mixed expired CO, was 46.9 Ϯ 12.8 ml⅐min Ϫ1 ⅐Torr
. NO dead space ϭ (VT ϫ FE NO Ϫ VT ϫ FA NO )/ (FI NO Ϫ FA NO ) ϭ 209 Ϯ 88 ml, where VT is tidal volume and FE NO , FI NO , and FA NO are mixed exhaled, inhaled, and alveolar NO concentrations, respectively. We used the Bohr equation to estimate CO 2 dead space from mixed exhaled and end-tidal (assumed alveolar) CO 2 ϭ 430 Ϯ 136 ml. Predicted anatomic dead space ϭ 199 Ϯ 22 ml. Membrane diffusing capacity was 333 and 166 ml⅐min Ϫ1 ⅐Torr Ϫ1 for NO and CO, respectively, and pulmonary capillary blood volume was 140 ml. Inhalation of repeated breaths of NO over 80 s did not alter DL NO at the concentrations used. alveolar capillary gas diffusion; dead space; membrane diffusing capacity; lung capillary blood volume THEORETICALLY, nitric oxide (NO) is the ideal gas to study lung diffusion because it is poorly soluble in water and, because of its very rapid and virtually irreversible reaction with Hb, its uptake is independent of pulmonary capillary blood flow and rate of chemical reaction (6) . Our laboratory (4) originally developed a single-breath method for measuring lung NO diffusion (DL NOSB ) during breath holding at rest. By including CO in the inspired mixture, it is possible to simultaneously measure the DL COSB . From knowledge of the water solubility and molecular weight of the two gases and by assuming that Roughton and Forster's model also applies to NO lung transfer, our laboratory (3) and others (8) have estimated the Dm and Vc from a single breath. The availability of rapidly responding and sensitive NO analyzers now allows estimation of alveolar NO concentrations from end-expiratory samples and hence measurement of steady-state DL NO (DL NOSS ) during tidal breathing using safe and stable NO concentrations.
These measurements are important for several reasons. NO is produced in high concentration (11) in the nose and taken up in the lung, so steady-state NO gas transfer takes place during everyday life and knowledge of DL NO is essential for understanding normal NO metabolism. Measuring diffusing capacity in animals and on maximal exercise in humans is easier using a steady-state method compared with a single-breath technique. Using Roughton and Forster's method for obtaining Dm and Vc from DL CO during steady-state breathing at two or more O 2 tensions is likely to overestimate the O 2 -dependent resistance (1/CO Vc) due to hyperoxia increasing regional inhomogeneity in diffusing capacity. Using DL NO and DL CO at a single, physiological value for Pc O 2 obviates this problem. Exhaled NO is being investigated as a test for inflammatory markers in lung disease. An increase in FE NO could result from increased NO production or from reduced DL NO (10) . Ill or ventilated patients will be unable to perform single exhalations from total lung capacity, so knowing DL NOSS is important in interpreting values for FE NO derived from tidal breathing measurements. Finally, inhaled NO is being used therapeutically to treat acute respiratory distress syndrome and pulmonary hypertension. NO causes ultrastructural oxidant lung injury when inhaled in concentrations of 6 ppm for 6 wk (12), and its safety depends on its fast removal into the pulmonary capillary blood before oxidation to nitrogen dioxide or other toxic products can occur. If patients have reduced DL NOSS , then toxicity may be enhanced and the inhaled NO concentration may need to be reduced.
For these reasons, we have made combined DL NOSS and DL COSS measurements in healthy volunteers by adapting the method of Bates et al. (1) . 
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METHODS
Subjects
Nine nonsmoking male subjects with no history of lung disease volunteered for the study. All signed consent forms approved by the Huntingdon district ethics committee, who also gave approval for this study. Their characteristics and DL COSB measured by the standard technique at rest (6) are listed in Table 1 . All subjects pursued a moderately active lifestyle.
General Method
On a daily basis, temperature and PB were measured by use of a metabolic cart (2900Z, Sensor Medics EME, Brighton, Sussex, England) calibrated against a mercury thermometer and the local meteorological office, respectively. PB was corrected for saturated vapor pressure by reference to a table (6) . Each subject performed one complete maneuver. Background atmospheric NO, CO 2 , and CO were measured. Each subject sat breathing air on an electronically braked bicycle ergometer (Sensor Medics 800S) and started to cycle, gradually building up speed until he achieved the desired level of moderate exercise (ϳ1 l/min V O 2 ). Once steady state was achieved, exhaled air was collected for a 2-min period to measure NO and CO back tension, and an 80-s record was also taken of intrabreath NO and CO 2 recording at the lips by arranging a fine-bore cannula within the mouthpiece to ensure zero dead space. They were then switched to a mixture of ϳ5,000 ppb NO and 0.1% CO in air stored in a 200-liter Douglas bag (PK Morgan, Gillingham, Kent, UK) prepared immediately before each replicate. A continuous 2-min collection of exhaled air was made from a similar Douglas bag attached to the exhaled port of the metabolic cart. VT on a breath-by-breath basis, RR, and V O 2 were recorded during this time from the metabolic cart. Volume was calibrated by using a 3-liter syringe. The O 2 analyzer of the metabolic cart was calibrated using three different O 2 concentrations (16%, 21%, and 26%). Immediately before and immediately after the period of exercise, the inspirate bag was analyzed for NO and CO.
Gas Analyses
NO and CO 2 were analyzed by using a rapidly responding instrument (Logan Research LR 2000, Rochester, UK) that directs the sample through a rapidly reacting infrared CO 2 analyzer to a chemiluminescent NO analyzer with a small (Ͻ10 ml) reaction chamber. The NO analyzer has four separate analysis modes for quantifying endogenous NO produced 1) through the nose, 2) during tidal breathing, and 3) during a maximal single exhalation and, finally, 4) a mode for analyzing inhaled concentrations during therapeutic use of NO. For this study, the instrument was set in "therapeutic" mode and calibrated using NO-free compressed air and 4,000 ppb and 80,000 ppb NO (manufacturer's certificate of analysis; BOC gases, Worsley, Manchester, UK). The CO 2 analyzer was calibrated using O 2 (CO 2 free), 5% and 6% CO 2 . To ensure linearity of these two analyzers, a serial dilution of a mix of NO and CO 2 over the working range was performed.
To measure the response time, a rubber balloon containing 2,660 ppb NO and 2.7% CO 2 was burst by pinprick. CO was analyzed by using the infrared analyzer of a standard gas transfer apparatus (Transfertest, PK Morgan, Chatham, Kent, UK). Linearity was tested by serially diluting a standard CO-He mix of 6% He and 0.1% CO in air to generate a 25-point plot of CO vs. He.
Blood Analyses
Venous blood was sampled immediately before each experiment and analyzed within 2 h for Hb, metHb, and COHb using an automated spectrophotometer (IL282, Instrument Laboratories, Cupertino, CA).
Safety Precautions
The exercise laboratory was kept well ventilated at all times. The stock NO cylinder (1,000 ppm in nitrogen) was kept securely fastened to the purpose-built trolley at all times. The inspired NO concentration in the Douglas bag was checked before inhalation and was continuously monitored breath by breath during the experiment.
Calculations
Alveolar NO and CO 2 . The NO, CO 2 , and time (in s) readings were downloaded as Excel spreadsheet files (Microsoft) from the Logan analyzer using the "datadump facility." For each individual, four files were created: mixed exhaled (breathing air on exercise), mixed exhaled (breathing NO and CO on exercise), inhaled (breathing NO and CO on exercise), and breath by breath (breathing NO and CO on exercise.) For the inhaled file, the concentrations were derived as the mean of the column of readings. For the breathby-breath files, X-Y plots of NO as a function of time and CO 2 as a function of time were drawn using a spreadsheet charting program (Works 3.1, Microsoft). The FA CO 2 was taken as one-third of the way along the alveolar plateau ( Fig. 1) (5) . For NO, the alveolar phase was identified visually as a stepwise reduction in the rate of fall of NO concentration with time (Fig. 2) , a line of best fit was drawn, and the concentration one-third of the way along was taken as FA NO . FE CO and FE NO were taken as the mean of the column of readings from the exhaled bag.
Dead space calculations. Anatomic dead space was estimated as 2.2 ϫ weight (kg) ϩ age in yr (6). CO 2 dead space (6) was calculated from
NO dead space was calculated as follows Volume of NO gas exhaled breathing NO mixture 
was calculated using the predicted anatomic dead space for both gases and, for CO, the CO 2 dead space (Eq. 1).
In addition, for NO, because we had a rapidly reacting NO analyzer, we adapted Bates et al.'s method using end-tidal concentrations [(c) D CO II in their paper] for NO and used end-tidal FE NO from the expired NO curve (Fig. 2) as an estimate of FA NO
There were thus two estimates of DL CO and DL NO per subject.
For dead space and DL calculations, the respiratory quotient was assumed to be 1 (see RESULTS) .
Calculation of Dm and Vc. Calculations were made as follows
Vc ϭ 1/͑CO/DL CO Ϫ CO/Dm CO ͒
Fig. 1. Change in exhaled NO concentration with time over 2 breaths. On the second curve, the method of fitting a straight line to the estimated NO alveolar plateau is shown. The value of 500 ppb is the estimated alveolar concentration one-third of the way along the plateau. For clarity, the figure has been drawn by using the line chart option of the Microsoft Excel chart wizard to simulate an analog output from the NO analyzer. Fig. 2 . Change in exhaled CO 2 concentration with time over 2 breaths. On the second curve, the method of fitting a straight line to the estimated alveolar CO 2 plateau is shown. The value of 6.5% is the estimated alveolar concentration one-third of the way along the plateau. For clarity, the figure has been drawn by using the line chart option of the Microsoft Excel chart wizard to simulate an analog output from the CO 2 analyzer.
For derivation of these equations, see Ref. 
Statistical Analysis
The paired t-test was used to compare the calculated NO dead space to the predicted anatomic dead space and to the CO 2 dead space and to compare DL NO calculated from FA NO and predicted anatomical dead space. Values are given as means Ϯ SD.
RESULTS
Performance of Analyzers
The NO-CO 2 analyzer was linear to serial dilution over the working range down to NO concentrations below 250 ppb and CO 2 below 0.55% when departure from linearity occurred; these were well below the alveolar and mixed expired concentrations. The minimum detectable concentration of NO was 60 ppb and CO 2 0.3% in therapeutic mode. The response time to half signal after balloon burst was 160 ms for CO 2 and 400 ms for NO; the CO 2 column was therefore "cut and pasted" down by 240 ms in the spreadsheet to synchronize concentration data for the two gases. A plot of CO and He was linear with intercept zero over the working CO range. Table 1 illustrates the nine subjects' physical characteristics.
Subject Data
Measured and Derived Variables
Mean V O 2 was 1.3 Ϯ 0.2 l/min. Mean respiratory quotient (RQ) was 0.96 Ϯ 0.06. No loss of NO or CO occurred from the inspired bag. There was no detectable (i.e., Ͻ60 ppb) background NO in the laboratory atmosphere or in the exhaled breath sample for any subject with the instrument in the therapeutic mode. The breath-by-breath X-Y plots of exhaled concentration and time are shown in Fig. 1 for CO 2 and Fig. 2 for NO. The NO plot comprises a peak of inhaled NO, a steep fall representing dead space, and then a shallower alveolar slope. The mean inhaled, mean mixed exhaled, and alveolar NO were 5,218 Ϯ 1,675, 1,402 Ϯ 381, and 942 Ϯ 250 ppb, respectively.
The calculated CO 2 and NO dead spaces are shown in Table 2 . The NO dead space is significantly different (P Ͻ 0.001) from the CO 2 dead space but not from the anatomic dead space. Calculated DL CO and DL NO together with Dm and Vc are shown in Tables 2 and 3 . There are no significant differences between the two estimates of DL NO . DL NO appears constant over 30 s of observation (Fig. 3) .
DISCUSSION
Major Findings
Estimates of dead space. The NO dead space is strikingly similar to the predicted anatomical dead space but significantly lower, on average about one-half, than the CO 2 dead space. However, the estimate of NO dead space is less precise because the alveolar slope for NO is Fig. 3 . Ratio of steady-state diffusing capacity for NO (DL NO ) to mean DL NO for the 9 subjects over ϳ30 s. DL NO was calculated by using mixed exhaled NO and breath-by-breath alveolar CO 2 concentration. NO . The values for DL NO using the predicted anatomic dead space and the dead space calculated from FA NO are similar ( Table 2 ). The higher mean value for DL NO calculated from FA NO is largely due to subject 3, who had wide between-breath variation in VT and FA NO . The average DL NOSS of ϳ200 ml ⅐ min Ϫ1 ⅐ Torr Ϫ1 measured here on moderate exercise exceeds the single-breath value measured at rest (125 ml ⅐ min Ϫ1 ⅐ Torr
Ϫ1
) by ϳ70 ml ⅐ min Ϫ1 ⅐ Torr Ϫ1 (4) . This is at first surprising because steady-state measurements are made at VT rather than total lung capacity and DL NOSB is highly lung volume dependent (4), falling by 45 ml ⅐ min Ϫ1 ⅐ Torr Ϫ1 with a reduction in VA from 7 to 4 liters. It is to be noted that it is the volume that the inhaled NO is distributed into rather than the inhaled volume that is important here. During steady-state breathing, the NO will be distributed into a volume of functional residual capacity plus VT, whereas during a single breath it will be distributed into VA. The difference between these volumes is perhaps only 1-2 liters. However, we also noted a rise in DL NOSB with exercise to 210 ml ⅐ min Ϫ1 ⅐ Torr Ϫ1 at 1-2 l/min V O 2 , so the overall value could be little changed. These average values therefore may be used to interpret values for alveolar partial pressure of NO in models of NO production (10) .
Values for DL CO , Dm, and Vc. The mean DL COSS on moderate exercise exceeds DL COSB measured at rest by ϳ5-10 ml ⅐ min Ϫ1 ⅐ Torr
. Our previous mean value for DL COSB at 1.4 l/min V O 2 in three individuals was 48 ml ⅐ min Ϫ1 ⅐ Torr
, so again it is possible that the discrepancy is due to exercise. Other workers have found DL COSS to be less than DL COSB (13) . Dm COSS is close to our previous value for Dm COSB (316 ml ⅐ min Ϫ1 ⅐ Torr Ϫ1 ). However, Vc is about three times as large (56 ml single breath) (3) . It is possible to use Eq. 7 to calculate Vc on exercise from our previous combined single-breath data (4) , and a figure of 101 ml is obtained. In contrast, Dm COSB is 343 ml ⅐ min Ϫ1 ⅐ Torr
. It would appear that during tidal breathing on exercise Vc is one to two times that which is measured during apnea at total lung capacity on exercise. One explanation is that the capillaries are flattened when the alveoli are fully inflated and stretched. Alternatively, maximal inspiration recruits alveoli that are normally less well ventilated, less well perfused, and hence of lower Vc. The increased cardiac output of exercise dilates capillaries and recruits capillaries, hence increasing Vc. All these processes have little effect on Dm because it is probable that NO uptake is largely independent of Vc. Variation in DL NO between breaths. It was not possible to perform a complete breath-by-breath analysis for DL NOSS . Although we could measure FA NO on a breathby-breath basis and inhaled NO would not have varied between breaths, it was not possible to calculate the mixed exhaled NO on a breath-by-breath basis. To do so would have needed exhaled flow or volume averaging of the exhaled NO signal, which is not possible with the analyzer in therapeutic mode. However, calculating DL NOSS by using FE NO and breath-by-breath FA NO does not show any alteration of DL NOSS with duration of inhalation or number of breaths (Fig. 3) . Despite NO being vasoactive, there appears to be no evidence that breathing it alters the measurement of DL NOSS .
Critique of Method
As with DL COSS , DL NOSS suffers from the inherent inaccuracy of estimating FA NO . We found a steep alveolar phase for exhaled NO (Fig. 2) , and the place on the curve chosen as a representative value for FA NO inevitably influenced DL NOSS to a great extent. DL NOSB measurements are therefore more reproducible (4). DL NOSS is more practical for exercise measurements, and indeed we studied DL NOSS on exercise because at rest DL COSS is greatly affected by regional inhomogeneity in diffusing capacity, and we anticipated similar problems with DL NOSS . It would have been of interest to monitor DL NOSS continuously during increasing exercise and to have several replicates per subject. However, this would have involved exposure to 5,000 ppb NO for many minutes over several days, and we thought that this could be unsafe given that there is uncertainty regarding the safe exposure concentrations for NO. This concentration was chosen because it is stable in air but sufficiently high for interference from endogenous NO not to be a problem. The steadystate method is more applicable to use during artificial ventilation in patients and for animal work.
Comparison With Other Work
All three groups who have made DL NO measurements have applied the classic Roughton and Forster model (1/DL ϭ 1/Dm ϩ1/Vc) originally derived for CO transfer to NO transfer, although each group has made different assumptions, leading to differing values for Dm and Vc. Guenard et al. (8) assumed that, because the rate of reaction of NO with Hb is extremely rapid compared with the membrane conductance (Dm), DL NO approximates to Dm NO and is therefore twice Dm CO because the ratio of water solubility to the square root of molecular weight for NO is twice that for CO. This value for Dm CO is entered into the equation. By their reasoning, DL NO is entirely independent of capillary blood volume. Using this approach yields lower figures for Dm and higher values for Vc than we have obtained (see Table 3 ). Their method and ours use upper and lower limits for and give correspondingly lower and upper limits for Dm and Vc. All the groups have assumed that NO is independent of alveolar PO 2 , although there is no in vitro evidence for this given the technical difficulties due to the rapid reaction of NO and O 2 . However, our laboratory (3) has previously found some O 2 variability of DL NO over the physiological PO 2 range and presumed this to be due to alteration in Dm or Vc.
Values for DL NO -to-DL CO ratio and the reaction resistance. The ratio of DL NO to DL CO varies between 3.9 and 4.8, depending on which estimates of DL are used. These estimates are rather lower than those made using single-breath estimates (4, 7) , perhaps because of the exercise-induced increase in DL CO .
Schuster and Heller (9) extended Guenard's formula and obtained the reaction resistance/total transfer resistance ϭ DL CO /COVc ϭ 1-2/(DL NO /DL CO ). With the use of Heller and Schuster's formula (9) , which assumes that NO is infinity, the reaction resistance to CO uptake from our data of 1-2/(DL NO /DL CO ) gives a figure of 0.48, which is close to their estimate (0.4). However, if the reaction resistance is calculated as DL CO /(CO ϫ Vc) using our value for Vc (Table 3 ) and using the O 2 -dependent term for CO (see calculation of Dm and Vc above), then a figure of 45.6/(158 ϫ 4.1 ϫ 10 Ϫ3 ϫ 100) ϭ 0.7 is obtained. It is clearly crucial to know the in vivo value of NO to correctly calculate the reaction resistance to CO uptake.
Directions for Further Work
It would be important to confirm our observations by making measurements at rest, increasing levels of exercise and varying PO 2 . A simultaneous rapidly responding flow or volume channel would allow breathby-breath measurement and also the study of withinbreath variation of DL NO with VA. The interpretation of DL NO and indeed DL CO crucially depends on how values for obtained in the laboratory relate to the situation in the pulmonary capillary. One approach would be to measure DL NO and DL CO simultaneously while varying the hematocrit. If 1/DL is plotted as a function of 1/Hb for both gases, then the ratio of slopes is NO/CO. These experiments would be best performed in an isolated lung preparation. Studies of DL NO /DL CO in anemia in humans have given conflicting results, no doubt because chronic anemia affects other aspects of gas transfer than hematocrit (2) . In an isolated lung model, it should be possible to keep these factors constant. (1,500 mmol ⅐ min Ϫ1 ⅐ kPa Ϫ1 ⅐ l Ϫ1 ) and CO (7) calculated from 1/CO ϭ 1.3 ϫ 10 Ϫ3 ϩ 4.1 ϫ 10 Ϫ3 (Pc O 2 ) min⅐Torr/ml
Ϫ1
. PcO 2 was taken as 100 Torr. For both CO and NO, correction for Hb was made by multiplying by Hb ϫ (1 Ϫ COHb Ϫ metHb)/14.6.
For subject 1, we used the estimate of DL CO using the CO 2 dead space and DL NO using end-tidal NO as an estimate of alveolar NO 
